Insider · CIK 0001416175

Nagler David

Reports to the SEC for 2 companies · FREMONT, CA

sec.gov

Transactions

Companies

Filings

CIK

0001416175

Forms 4 and 5

Insider transactions

17 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2018-06-20	Audentes Therapeutics, Inc.M Exercise/Conversion	SVP, HR & Corp. Affairs	MExercise/Conversion	+4,700 sh	$2.19	+$10.3K	4,700
2018-06-20	Audentes Therapeutics, Inc.S Sale	SVP, HR & Corp. Affairs	SSale	−4,700 sh	$45.25	−$213K	0
2018-06-20	Audentes Therapeutics, Inc.M Exercise/Conversion	SVP, HR & Corp. Affairs	MExercise/Conversion	+300 sh	$2.19	+$655.56	300
2018-06-20	Audentes Therapeutics, Inc.S Sale	SVP, HR & Corp. Affairs	SSale	−300 sh	$46.02	−$13.8K	0
2018-06-20	Audentes Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	SVP, HR & Corp. Affairs	MExercise/Conversion	−5,000 sh	—	—	32,347
2017-11-16	Audentes Therapeutics, Inc.Stock Option (right to buy)A Award	SVP, HR & Corp. Affairs	AAward	+50K sh	—	—	50,000
2017-09-27	Audentes Therapeutics, Inc.M Exercise/Conversion	SVP, HR & Corp. Affairs	MExercise/Conversion	+3,750 sh	$2.19	+$8,194.5	3,750
2017-09-27	Audentes Therapeutics, Inc.S Sale	SVP, HR & Corp. Affairs	SSale	−3,750 sh	$30.00	−$113K	0
2017-09-27	Audentes Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	SVP, HR & Corp. Affairs	MExercise/Conversion	−3,750 sh	—	—	37,347
2017-09-15	Audentes Therapeutics, Inc.M Exercise/Conversion	SVP, HR & Corp. Affairs	MExercise/Conversion	+3,750 sh	$2.19	+$8,194.5	3,750
2017-09-15	Audentes Therapeutics, Inc.S Sale	SVP, HR & Corp. Affairs	SSale	−3,750 sh	$25.00	−$93.8K	0
2017-09-15	Audentes Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	SVP, HR & Corp. Affairs	MExercise/Conversion	−3,750 sh	—	—	41,097
2017-01-25	Audentes Therapeutics, Inc.Stock Option (right to buy)A Award	SVP, HR & Corp. Affairs	AAward	+50K sh	—	—	50,000
2010-02-25	ARYx Therapeutics, Inc.Restricted Stock UnitsA Award	V.P.,Corp. Affairs & Sect.	AAward	+130K sh	—	—	130,000
2009-12-21	ARYx Therapeutics, Inc.G Gift	V.P.,Corp. Affairs & Sect.	GGift	−1,250 sh	—	—	1,837
2009-12-21	ARYx Therapeutics, Inc.G Gift	V.P.,Corp. Affairs & Sect.	GGift	+1,000 sh	—	—	1,000
2009-02-18	ARYx Therapeutics, Inc.Stock Option (Right to Buy)A Award	V.P.,Corp. Affairs & Sect.	AAward	+60K sh	—	—	60,000

Recent filings

Accepted (ET)
Jun 224
Nagler David0001209191-18-039316
SEC(opens sec.gov)
Nov 174
Nagler David0001209191-17-061539
SEC(opens sec.gov)
Sep 294
Nagler David0001209191-17-054440
SEC(opens sec.gov)
Sep 194
Nagler David0001209191-17-053350
SEC(opens sec.gov)
Jan 274
Audentes Therapeutics, Inc.0001209191-17-005996
SEC(opens sec.gov)
Mar 24
Nagler David0001179110-10-004115
SEC(opens sec.gov)
Feb 115
Nagler David0001179110-10-002620
SEC(opens sec.gov)
Feb 204
Nagler David0001179110-09-003094
SEC(opens sec.gov)

Companies

Address

C/O ARYX THERAPEUTICS, INC. 6300 DUMBARTON CIRCLE

FREMONT, CA, 94555